Biblio
Export 1125 results:
Author Title [ Type
Filters: First Letter Of Last Name is T [Clear All Filters]
“Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
, “Predictors of Discharge Destinations and Three-Month Evolution of Patients Initially Hospitalized in a Cognitive Behavioral Unit.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1259-1266, 2017.
, “Predictors of Delirium Development in Older Medical Inpatients: Readily Identifiable Factors at Admission.”, J Alzheimers Dis, vol. 64, no. 3, pp. 775-785, 2018.
, “Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 717-728, 2018.
, “Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.”, J Alzheimers Dis, 2018.
, “Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.”, J Alzheimers Dis, 2018.
, “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
, “Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1229-1244, 2017.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.”, J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
, “Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
, “Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 691-701, 2017.
, “Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 691-701, 2017.
, “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
, “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
, “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
, “Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, 2018.
, “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
, “Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 203-215, 2018.
, “Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.”, J Alzheimers Dis, vol. 81, no. 2, pp. 451-458, 2021.
, “Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1453-9, 2016.
, “Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1453-9, 2016.
, “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
, “Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.”, J Alzheimers Dis, vol. 72, no. 2, pp. 479-494, 2019.
, “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
,